Abeona Receives Breakthrough Designation for Rare Skin Disease Gene Therapy
August 31st 2017A gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), a rare skin disease that causes the skin to be very fragile and blister easily, has been granted Breakthrough Therapy designation status by the FDA.